IRIS
MALERBA, Mario
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.689
NA - Nord America 3.345
AS - Asia 2.543
SA - Sud America 694
AF - Africa 98
Continente sconosciuto - Info sul continente non disponibili 12
OC - Oceania 2
Totale 10.383
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.268
IE - Irlanda 1.097
SG - Singapore 829
HK - Hong Kong 606
DE - Germania 556
BR - Brasile 552
CN - Cina 489
IT - Italia 484
SE - Svezia 392
UA - Ucraina 390
RU - Federazione Russa 312
VN - Vietnam 288
FR - Francia 154
GB - Regno Unito 87
KR - Corea 78
AR - Argentina 61
IN - India 58
FI - Finlandia 55
ID - Indonesia 49
BJ - Benin 46
NL - Olanda 40
CA - Canada 39
EC - Ecuador 27
PL - Polonia 25
MX - Messico 24
BD - Bangladesh 23
ZA - Sudafrica 23
JP - Giappone 19
PK - Pakistan 19
AT - Austria 18
BE - Belgio 18
CO - Colombia 16
ES - Italia 14
IQ - Iraq 12
CL - Cile 11
EU - Europa 11
LT - Lituania 11
TR - Turchia 11
CZ - Repubblica Ceca 10
SA - Arabia Saudita 9
IR - Iran 8
AE - Emirati Arabi Uniti 6
AZ - Azerbaigian 6
CH - Svizzera 6
DZ - Algeria 6
PE - Perù 6
PH - Filippine 6
PY - Paraguay 6
UZ - Uzbekistan 6
VE - Venezuela 6
EG - Egitto 5
JO - Giordania 5
MA - Marocco 5
UY - Uruguay 5
TN - Tunisia 4
BO - Bolivia 3
DO - Repubblica Dominicana 3
KE - Kenya 3
RO - Romania 3
RS - Serbia 3
AL - Albania 2
AM - Armenia 2
AO - Angola 2
CR - Costa Rica 2
EE - Estonia 2
GR - Grecia 2
GT - Guatemala 2
KG - Kirghizistan 2
KW - Kuwait 2
NP - Nepal 2
SV - El Salvador 2
AU - Australia 1
BG - Bulgaria 1
BH - Bahrain 1
BW - Botswana 1
CD - Congo 1
ET - Etiopia 1
GE - Georgia 1
GY - Guiana 1
HN - Honduras 1
HU - Ungheria 1
IL - Israele 1
IS - Islanda 1
JM - Giamaica 1
KH - Cambogia 1
KZ - Kazakistan 1
LV - Lettonia 1
MG - Madagascar 1
MK - Macedonia 1
MN - Mongolia 1
MT - Malta 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PT - Portogallo 1
QA - Qatar 1
TT - Trinidad e Tobago 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 10.383
Salva come PNG Salva come JPEG
Città #
Dublin 1.090
Jacksonville 749
Hong Kong 606
Dearborn 365
Singapore 266
Ashburn 249
Beijing 237
Lawrence 142
Princeton 142
Wilmington 141
San Mateo 121
Los Angeles 113
Moscow 97
Ann Arbor 93
Ho Chi Minh City 90
Seoul 77
Hanoi 74
Chandler 71
Buffalo 66
São Paulo 54
Novara 49
Redondo Beach 47
Cotonou 46
Houston 40
Munich 39
Piemonte 39
Milan 38
Helsinki 37
New York 36
Seattle 32
Rome 26
Turin 26
Jakarta 24
Nanjing 22
Dallas 21
Torino 21
Warsaw 21
Nuremberg 20
Rio de Janeiro 20
Brussels 18
Dong Ket 18
Hefei 18
Norwalk 17
Woodbridge 17
Atlanta 16
Boardman 16
Denver 16
Haiphong 16
Tokyo 16
Viggiano 16
Stockholm 15
Andover 14
Kunming 14
Santa Clara 14
Turku 14
Johannesburg 13
Assago 12
Chennai 12
Nanchang 12
Poplar 12
Toronto 12
London 11
Montreal 11
Orem 11
Quito 11
Thái Bình 11
Brno 10
Frankfurt am Main 10
Quetta 10
Saint Louis 10
Amsterdam 9
Belo Horizonte 9
Bremen 9
Brooklyn 9
Jinan 9
Mauá 9
Mexico City 9
Paris 9
Recife 9
Alba 8
Alessandria 8
Boston 8
Curitiba 8
Dhaka 8
Guangzhou 8
Brasília 7
Brescia 7
Campinas 7
Grafing 7
Monza 7
Phoenix 7
San Francisco 7
Vienna 7
Baku 6
Berlin 6
Falkenstein 6
Guayaquil 6
Philadelphia 6
Ribeirão Preto 6
Santo André 6
Totale 6.097
Salva come PNG Salva come JPEG
Nome #
Machine learning risk prediction of mortality for patients undergoing surgery with perioperative SARS-CoV-2: the COVIDSurg mortality score 266
Fatality rate and predictors of mortality in an Italian cohort of hospitalized COVID-19 patients 204
Simple Parameters from Complete Blood Count Predict In-Hospital Mortality in COVID-19 149
Interrelationship between COVID-19 and Coagulopathy: Pathophysiological and Clinical Evidence 146
Correction to: Analysis of common methodological flaws in the highest cited e-cigarette epidemiology research 142
Contribution of Atrial Fibrillation to In-Hospital Mortality in Patients With COVID-19 138
Change over time of COVID-19 hospital presentation in Northern Italy 132
Role of beta-blockers in patients with COPD: current perspective. 126
Clinical outcome with different doses of low-molecular-weight heparin in patients hospitalized for COVID-19 119
DGKα in Neutrophil Biology and Its Implications for Respiratory Diseases 118
Outcomes of COVID-19 patients treated with continuous positive airway pressure outside ICU 115
Ambroxol in the 21st century: pharmacological and clinical update 106
Identification of Key Phospholipids That Bind and Activate Atypical PKCs 104
[Alpha 1-antitrypsin deficiency: the Brescia clinical study]. FT Il deficit di alpha 1-antitripsina: lo studio clinico di Brescia. 102
Interrelationship among Obstructive Sleep Apnea,Renal Function and Survival: A Cohort Study 96
Acute respiratory distress following intravenous injection of trichloroethylene 94
Wiskott-Aldrich syndrome protein interacts and inhibits diacylglycerol kinase alpha promoting IL-2 induction 92
Association of FEF25-75% Impairment with Bronchial Hyperresponsiveness and Airway Inflammation in Subjects with Asthma-Like Symptoms 91
Age-Related Increase of Airway Neutrophils in Older Healthy Nonsmoking Subjects 89
Acute exacerbation of idiopathic pulmonary fibrosis: lessons learned from acute respiratory distress syndrome? 87
Aging and induced-sputum cells 86
Analysis of mitochondrial DNA alteration in new phenotype ACOS 86
Determinants of smoking status in a sample of outpatients afferent to a tertiary referral hospital 86
EXHALED NITRIC OXIDE AS A MARKER OF LUNG INVOLVEMENT IN CROHN'S DISEASE 85
A randomized trial of cefepime and ceftazidime for the treatment of community-acquired pneumonia 85
Analysis of local T lymphocyte subsets upon stimulation with intravesical BCG: A model to study tuberculosis immunity 81
[Pharmacologic control of breathing]. FT Controllo farmacologico della ventilazione. 78
Circulating Peptidome Is Strongly Altered in COVID-19 Patients 77
ACUTE VENTILATORY AND GAS-EXCHANGE EFFECTS OF A NEW BETA-2 AGONIST, BROXATEROL, IN ASTHMATICS 76
Biological investigations | [Indagini biologiche] 76
Long term adjustment of stable asthma treatment with fractional exhaled nitric oxide and sputum eosinophils 74
Airway hyperresponsiveness in a large group of subjects with alpha(1)-antitrypsin deficiency: a cross-sectional controlled study 74
Effects of beta 2-agonists during cardiopulmonary exercise test in COPD patients. 73
Analysis of the fungal microbiome in exhaled breath condensate of patients with asthma. 73
Late Breaking Abstract- New imaging approach to evaluate the in vivo administration of nanostructured mycophenolic acid in a preclinical model of SSC-ILD 72
THE POTENTIAL THERAPEUTIC ROLE OF POTASSIUM CHANNEL MODULATORS IN ASTHMA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE 72
[Infective pneumopathies in old age]. FT Pneumopatie infettive in eta geriatrica. 71
DOXAZOSIN IN THE TREATMENT OF HYPERTENSION IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY-DISEASE 71
[Severe alpha 1-antitrypsin deficiency: cross sectional clinical study]. FT Grave deficit di alpha 1-antitripsina: studio clinico trasversale. 70
Potential role of diacylglycerol kinases in immune-mediated diseases 69
[General practitioner and respiratory medicine specialist. A survey on the management of the asthmatic patient]. FT Indagine conoscitiva sul rapporto tra medico di medicina generale e specialista in medicina respiratoria nella gestione clinica del paziente asmatico. 68
Micellar electrokinetic chromatography determination of desmosine in urine from patients with chronic lung disease. 68
Exhaled nitric oxide levels in systemic sclerosis with and without pulmonary involvement 68
The potential role of endothelial dysfunction and platelet activation in the development of thrombotic risk in COPD patients 68
Glucocorticoid-induced osteoporosis in asthma and respiratory diseases 68
Psoriasis and risk of myocardial infarction 67
Ineffectiveness of intravenous beta(2)-agonists on improving exercise tolerance in patients with reversible chronic airway obstruction 67
Potential role of hematological parameters in patients with chronic obstructive pulmonary disease: current point of view 67
[Tracheal stenosis due to metastatic adenopathic compression from breast carcinoma]. FT Stenosi tracheale per compressione adenopatica metastatica da carcinoma della mammella. 66
[Changes in the heart rhythm and slow-release beta-2 agonist therapy (peroral) in asthmatic patients. A Holter study]. Alterazioni del ritmo cardiaco e terapia beta-2-agonista a lento rilascio (per via orale) in pazienti asmatici. Studio Holter. 66
Vilanterol trifenatate for the treatment of COPD. 66
Biological investigations in pulmonology [Indagini biologiche in pneumologia] 66
Comorbid insomnia and obstructive sleep apnea (Comisa): Current concepts of patient management 65
Exhaled Nitric Oxide as a Biomarker in COPD and Related Comorbidities 65
Identification of IL-17F/frequent exacerbator endotype in asthma 65
Investigational beta-2 adrenergic agonists for the treatment of chronic obstructive pulmonary disease. 64
[Rhinitis and asthma]. FT Rinite e asma. 64
Effect of acute exacerbations on circulating endothelial, clotting and fibrinolytic markers in COPD patients. 64
Single-inhaler triple therapy utilizing the once-daily combination of fluticasone furoate, umeclidinium and vilanterol in the management of COPD: the current evidence base and future prospects 64
Narrow-band ultraviolet b phototherapy in psoriasis reduces pro-inflammatory cytokine levels and improves vitiligo and neutrophilic asthma 64
Biological investigations | [Indagini biologiche] 64
Effect of two beta(2)-agonist drugs, salbutamol and broxaterol, on the growth hormone response to exercise in adult patients with asthmatic bronchitis 63
UPPER EXTREMITY DEEP VEIN THROMBOSIS AS AN UNCOMMON COMPLICATION OF PACEMAKER IMPLANTATION: A CASE REPORT 62
Nasal IL-17F is related to bronchial IL-17F/neutrophilia and exacerbations in stable atopic severe asthma 62
PNEUMOLOGY 62
Neutrophilic inflammation and IL-8 levels in induced sputum of alpha-1-antitrypsin PiMZ subjects 62
[Respiratory effects of antihypertensive agents acting on alpha adrenergic receptors]. Effetti respiratori dei farmaci antiipertensivi che agiscono sui recettori alfa adrenergici. 62
Exosomes in chronic respiratory diseases 62
Dupilumab for the treatment of asthma 61
The discovery and development of aclidinium bromide for the treatment of chronic obstructive pulmonary disease 61
Biological investigation in respiratory medicine [Indagini biologiche in pneumologia] 61
Platelet activation as a novel mechanism of atherothrombotic risk in chronic obstructive pulmonary disease 60
Triple inhaled therapy for chronic obstructive pulmonary disease 59
Efficacy of Andolast in Mild to Moderate Asthma: A Randomized, Controlled, Double-Blind Multicentre Study (The ANDAST Trial) 59
Use of adjunct cardiovascular therapy in patients hospitalised for acute exacerbations of COPD 59
Lower limb deep vein thrombosis in COVID-19 patients admitted to intermediate care respiratory units 59
Cardiorespiratory intermediate intensive unit: heart-lung interactions. 58
Biologic and pharmacologic therapies in clinical development for the inflammatory response in COPD 58
Increased airway inflammation in patients with psoriasis 58
Bone ultrasonometric features and growth hormone secretion in asthmatic patients during chronic inhaled corticosteroid therapy 58
Exhaled nitric oxide in patients with alpha 1 antitrypsin (AAT) deficiency. 57
Growth hormone response to growth hormone-releasing hormone is reduced in adult asthmatic patients receiving long-term inhaled corticosteroid treatment 57
COVID-19 and Obesity: Dangerous Liaisons 57
Values in Elderly People for Exhaled Nitric Oxide Study 57
SUB-CLINICAL LEFT VENTRICULAR DIASTOLIC DYSFUNCTION IN EARLY STAGE OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE 57
Investigational prostaglandin D2 receptor antagonists for airway inflammation. 56
Series "novelties in pulmonary rehabilitation": Determinants of success 56
Exhaled breath temperature measurement: Influence of circadian rhythm 56
Ceftizoxlme for the treatment of exacerbations of chronic obstructive pulmonary diseases 55
Uremic lung. 55
Pharmacological treatment of chronic obstructive pulmonary disease: from evidence-based medicine to phenotyping 55
Diagnosis of Chronic Obstructive Pulmonary Disease, simpler is better Complexity and simplicity 55
Single inhaler LABA/LAMA for COPD 55
Critical appraisal of the European Union Scientific Committee on Health, Environmental and Emerging Risks (SCHEER) Preliminary Opinion on electronic cigarettes 55
Sleep apnea and psoriasis: A cohort study 54
Impact of exclusive e-cigarettes and heated tobacco products use on muco-ciliary clearance 54
Usefulness of Exhaled Nitric Oxide and Sputum Eosinophils in the Long-term Control of Eosinophilic Asthma 54
Cardiac arrhythmia monitoring during bronchial provocation test with methacholine 54
ERYTHROCYTE POTASSIUM CONTENT AND ACID-BASE-EQUILIBRIUM IN PATIENTS WITH HEPATIC CIRRHOSIS - EFFECT OF ORAL POTASSIUM-CHLORIDE ADMINISTRATION 54
SEVERE INTRAVASCULAR HAEMOLYSIS AS DELAYED MANIFESTATION OF PERIVALVULAR LEAK IN PATIENTS WITH MITRAL VALVE REPLACEMENT: A REPORT OF TWO CASES 54
Totale 7.688
Salva come PNG Salva come JPEG
Categoria #
all - tutte 59.684
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 59.684
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021521 0 0 0 0 0 26 146 7 151 20 143 28
2021/2022979 39 13 142 93 63 21 53 27 98 19 124 287
2022/20231.707 156 89 61 20 31 77 61 70 1.049 13 60 20
2023/2024707 43 47 32 25 130 12 81 20 13 7 150 147
2024/20251.863 23 15 42 28 36 114 181 148 530 265 102 379
2025/20262.796 247 230 553 1.093 584 89 0 0 0 0 0 0
Totale 10.638